Literature DB >> 21163499

Echocardiographic-based treatment of functional tricuspid regurgitation.

Antonio M Calafiore1, Angela L Iacò, Antonella Romeo, Salvatore Scandura, Rocco Meduri, Egidio Varone, Michele Di Mauro.   

Abstract

OBJECTIVES: Functional tricuspid regurgitation (FTR) worsens over time, and its natural history is unfavorable. An aggressive surgical strategy, using the echocardiographic systolic dimensions of the tricuspid annulus (sysTA), can be helpful to reduce the detrimental late effects of FTR.
METHODS: From March 2006 to February 2008, 298 patients, with at least FTR grade 1+, underwent mitral valve surgery. Of these 298 patients, 167 underwent tricuspid repair (treated group [T], moderate-or-greater FTR in 108 and mild in 59, with sysTA > 24 mm) and 137 did not (untreated group [UT], moderate-or-greater FTR in 16 and mild in 115; 81 with sysTA > 24 mm and 34 with sysTA of ≤ 24 mm). The 256 survivors underwent echocardiographic examination at a mean follow-up of 13 ± 8 months.
RESULTS: Preoperatively, at discharge, and at the follow-up examination, the mean FTR grade was 1.11 ± 0.32, 0.87 ± 0.49, and 1.03 ± 0.57 (P = NS) in the UT group and 2.11 ± 0.92, 0.45 ± 0.36, and 0.48 ± 0.32 (P < .001) in the T group. A total of 24 patients had FTR grade 2 or greater, 16 (14.5%) in the UT group and 8 (5.5%) in the T group (P = .026). In the UT group, 10 of 16 patients had sysTA of 25 to 28 mm and 6 of 10 had sysTA greater than 28 mm. No patient with mild FTR and sysTA of 24 mm or less had an increased FTR grade. Globally, 12 patients (10.9%) had an increased FTR grade in the UT group versus none in the T group (P < .001). Patients with postoperative atrial fibrillation had less residual FTR if annuloplasty had been performed (1.6 ± 0.7 vs 0.91 ± 0.63, P = .005).
CONCLUSIONS: An aggressive strategy for FTR correction, using the sysTA, was able to reduce the FTR grade 1 year after surgery, but mitral surgery alone could not.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21163499     DOI: 10.1016/j.jtcvs.2010.04.047

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Adjustable tricuspid annuloplasty.

Authors:  Hiroshi Iida; Toru Sunazawa; Syunichi Kondo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-02

2.  Reoperations after tricuspid valve repair: re-repair versus replacement.

Authors:  Ho Young Hwang; Kyung-Hwan Kim; Ki-Bong Kim; Hyuk Ahn
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

3.  Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

Authors:  James S Gammie; Michael W A Chu; Volkmar Falk; Jessica R Overbey; Alan J Moskowitz; Marc Gillinov; Michael J Mack; Pierre Voisine; Markus Krane; Babatunde Yerokun; Michael E Bowdish; Lenard Conradi; Steven F Bolling; Marissa A Miller; Wendy C Taddei-Peters; Neal O Jeffries; Michael K Parides; Richard Weisel; Mariell Jessup; Eric A Rose; John C Mullen; Samantha Raymond; Ellen G Moquete; Karen O'Sullivan; Mary E Marks; Alexander Iribarne; Friedhelm Beyersdorf; Michael A Borger; Arnar Geirsson; Emilia Bagiella; Judy Hung; Annetine C Gelijns; Patrick T O'Gara; Gorav Ailawadi
Journal:  N Engl J Med       Date:  2021-11-13       Impact factor: 91.245

4.  Right heart chamber geometry and tricuspid annulus morphology in patients undergoing mitral valve repair with and without tricuspid valve annuloplasty.

Authors:  Gloria Tamborini; Laura Fusini; Manuela Muratori; Paola Gripari; Sarah Ghulam Ali; Cesare Fiorentini; Mauro Pepi
Journal:  Int J Cardiovasc Imaging       Date:  2016-01-28       Impact factor: 2.357

5.  Hospital outcome of concomitant tricuspid annuloplasty during totally endoscopic mitral valve surgery: a propensity matched study.

Authors:  Ling-Chen Huang; Qi-Chen Xu; Dao-Zhong Chen; Xiao-Fu Dai; Liang-Wan Chen
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

Review 6.  The Dark Side of the Moon: The Right Ventricle.

Authors:  Massimiliano Foschi; Michele Di Mauro; Fabrizio Tancredi; Carlo Capparuccia; Renata Petroni; Luigi Leonzio; Silvio Romano; Sabina Gallina; Maria Penco; Mario Cibelli; Antonio Calafiore
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-20

7.  Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair.

Authors:  Hiroshi Takano; Miyoko Hiramatsu; Hirota Kida; Mitsuru Uenoyama; Kei Horiguchi; Takashi Yamauchi; Keiwa Kin; Yukitoshi Shirakawa; Mitsunori Kaneko; Takashi Daimon
Journal:  Surg Today       Date:  2016-08-08       Impact factor: 2.549

8.  Longitudinal echocardiographic and clinical follow-up of patients undergoing mitral valve surgery without concomitant tricuspid valve repair.

Authors:  R Jansen; B R van Klarenbosch; M J Cramer; R C A Meijer; P H M Westendorp; H W J Meijburg; J J J Bucx; S A J Chamuleau; J Kluin
Journal:  Neth Heart J       Date:  2018-11       Impact factor: 2.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.